Effect of biofeedback electrical stimulation combined with HoLEP on surgical outcomes in patients with benign prostatic hyperplasia complicated with detrusor underactivity: a retrospective cohort study - Takeaways - MDSpire

Effect of biofeedback electrical stimulation combined with HoLEP on surgical outcomes in patients with benign prostatic hyperplasia complicated with detrusor underactivity: a retrospective cohort study

  • By

  • Tengfei Gu

  • Jie Li

  • Ting Chen

  • Yongtao Pan

  • Qinzhou Yu

  • Jing Sha

  • May 25, 2026

  • 0 min

Share

  • 1

    Biofeedback electrical stimulation combined with HoLEP significantly improves voiding function in BPH patients with detrusor underactivity.

  • 2

    The intervention group demonstrated higher maximum urinary flow rates and bladder contractility indices compared to the control group postoperatively.

  • 3

    Patients receiving combined treatment reported lower International Prostate Symptom Scores and improved quality of life at three months.

  • 4

    Postoperative complications, including urinary tract infections and incontinence, were significantly lower in the intervention group.

  • 5

    The study supports the clinical benefits and safety of combining biofeedback electrical stimulation with HoLEP for BPH patients.

Original Source(s)

Effect of biofeedback electrical stimulation combined with HoLEP on surgical outcomes in patients with benign prostatic hyperplasia complicated with detrusor underactivity: a retrospective cohort study

  • by Tengfei Gu, Jie Li, Ting Chen, Yongtao Pan, Qinzhou Yu, Jing Sha

  • May 25, 2026

Related Content

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

Identification of succinylation-related genes in bladder cancer: integration of single-cell and transcriptomic data

Integrative oncology along with systemic cancer therapies in advanced bladder and prostate cancer: metabolic optimization guiding the shift from palliative care to clinical remission – a case report